Application of quantitative structure-activity relationships to the modeling of antitubercular compounds. 1. The hydrazide family

Journal of Medicinal Chemistry

Volumn 51, Issue 3, 2008, Pages 612-624

  Ventura, Cristina ^a,b   Martins, Filomena ^a  

^a UNIVERSITY OF LISBON   (Portugal)

^b Instituto Superior de Educação e Ciêcias   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

HYDRAZIDE DERIVATIVE; HYDRAZONE DERIVATIVE; ISONIAZID; ISONIAZID DERIVATIVE; TUBERCULOSTATIC AGENT;

ANTIBACTERIAL ACTIVITY; ARTICLE; LIPOPHILICITY; MOLECULAR MODEL; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

ANTITUBERCULAR AGENTS; CHEMISTRY, PHYSICAL; DATABASES, FACTUAL; HYDRAZINES; HYDROPHOBICITY; ISONIAZID; MODELS, MOLECULAR; MYCOBACTERIUM TUBERCULOSIS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 39149112263     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm701048s     Document Type: Article

References (55)

1. http://www.who.int/tb/en/ (accessed July 2007).
2. Zhang, Y. The Magic Bullets and Tuberculosis Drug Targets. Annu. Rev. Pharmacol Toxicol. 2005, 45, 529-564.
3. Global Tuberculosis Control: Surveillance, Planning, Financing; WHO Report 2006; World Health Organization: Geneva, 2006.
4. http://www.stoptb.org/ (accessed July 2007).
5. Ghiladi, R. A.; Medzihradszky, K. F.; Rusnak, F. M.; Montellano, P. R. O. Correlation between Isoniazid Resistance and Superoxide Reactivity in Mycobacterium tuberculosis. J. Am. Chem. Soc. 2005, 127, 13428-13442.
6. Scior, T.; Morales, I. M.; Eisele, S. J. G.; Domeyer, D.; Laufer, S. Antitubercular Isoniazid and Drug Resistance of Mycobacterium tuberculosis. A Review. Arch. Pharm. (Weinheim, Ger.) 2002, 11, 511-525.
7. Wengenack, N. L.; Rusnak, F. Evidence for Isoniazid-Dependent Free Radical Generation Catalyzed by Mycobacterium tuberculosis KatG and the Isoniazid-Resistant Mutant KatG(S315T). Biochemistry 2001, 40, 8990-8996.
8. Rozwarski, D. A.; Grant, G. A.; Barton, D. H. R.; Jacobs, W. R.; Sacchettini, J. C. Modification of the NADH of the Isoniazid Target (InhA) from Mycobacterium tuberculosis. Science 1998, 279, 98-102.
9. Ducasse-Cabanot, S.; Cohen-Gonsaud, M.; Marrakchi, H.; Nguyen, M.; Zerbib, D.; Bernadou, J.; Daffé, M.; Labesse, G.; Quémard, A. In Vitro Inhibition of the Mycobacterium tuberculosis β-Ketoacyl-Acyl Carrier Protein Reductase MabA by Isoniazid. Antimicrob. Agents Chemother. 2004, 48, 242-249.
10. Johnsson, K.; Schultz, P. G. Mechanistic Studies of the Oxidation of Isoniazid by the Catalase Peroxidase from Mycobacterium tuberculosis. J. Am. Chem. Soc. 1994, 116, 7425-7426.
11. Klopman, G.; Fercu, D.; Jacob, J. Computer-Aided Study of the Relationship between Structure and Antituberculosis Activity of a Series of Isoniazid Derivatives. Chem. Phys. 1996, 204, 181-193.
12. Seydel, J. K.; Schaper, K.-J.; Wempe, E.; Cordes, H. P. Mode of Action and Quantitative Structure-Activity Correlations of Tuberculostatic Drugs of the Isonicotinic Acid Hydrazide Type. J. Med. Chem. 1976, 19, 483-492.
13. Bagchi, M. C.; Maiti, B. C.; Mills, D.; Basak, S. C. Usefulness of Graphical Invariants in Quantitative Structure-Activity Correlations of Tuberculostatic Drugs of the Isonicotinic Acid Hydrazide Type. J. Mol. Model. 2004, 10, 102-111.
14. Saint-Joanis, B.; Souchon, H.; Wilming, M.; Johnsson, K.; Alzari, P. M.; Cole, S. T. Use of Site-Directed Mutagenesis To Probe the Structure, Function and Isoniazid Activation of the Catalase/Peroxidase, KatG, from Mycobacterium tuberculosis. Biochemistry 1999, 338, 753-760.
15. Wilming, M.; Johnsson, K. Spontaneous Formation of the Bioactive Form of the Tuberculosis Drug Isoniazid. Angew. Chem., Int. Ed. 1999, 38, 2588-2590.
16. Nguyen, M.; Quémard, A.; Broussy, S.; Benadou, J.; Meunier, B. Mn(III) Pyrophosphate as an Efficient Tool for Studying the Mode of Action of Isoniazid on the InhA Protein of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 2002, 46, 2137-2144.
17. Timmins, G.; Master, S.; Rusnak, F.; Dereic, V. Requirements for Nitric Oxide Generation from Isoniazid Activation in Vitro and Inhibition of Mycobacterial Respiration in Vivo. J. Bacteriol. 2004, 186, 5427-5431.
18. Timmins, G.; Master, S.; Rusnak, F.; Dereic, V. Nitric Oxide Generated from Isoniazid Activation by KatG: Source of Nitric Oxide and Activity against Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 2004, 48, 3006-3009.
19. v. Bioorg. Med. Chem. Lett. 2005, 15, 1803-1806.
20. Testa, B.; Crivori, P.; Reist, M.; Carrupt, P. A. The Influence of Lipophilicity on the Pharmacokinetic Behavior of Drugs: Concepts and Examples. Perspect. Drug Discovery Des. 2000, 19, 179-211.
21. (a) Platts, J. A.; Butina, D.; Abraham, M. H.; Hersey, A. Estimation of Molecular Linear Free Energy Relation Descriptors by a Group Contribution Approach. J. Chem. Inf. Comput. Sci. 1999, 39, 835-845.
22. (b) Abraham, M. H.; Ibrahim, A.; Zissimos, A. M.; Zhao, Y. H.; Comer, J.; Reynolds, D. P. Application of Hydrogen Bonding Calculations in Property Based Drug Design. Drug Discovery Today 2002, 7, 1056-1063.
23. Leo, A.; Hansch, C.; Elkins, D. Partition Coefficients and Their Uses. Chem. Rev. 1971, 71, 525-616.
24. Mohamad, S.; Ibrahim, P.; Sadikun, A. Susceptibility of Mycobacterium tuberculosis to Isoniazid and Its Derivative, 1-Isonicotinyl-2-nonanoyl hydrazine: Investigation at Cellular Level. Tuberculosis 2004, 84, 56-62.
25. De Logu, A.; Onnis, V.; Saddi, B.; Congiu, C.; Schivo, M. L.; Cocco, M. T. Activity of a New Class of Isonicotinoylhydrazones Used Alone and in Combination with Isoniazid, Rifampicin, Ethambutol, Para-aminosalicylic Acid and Clofazimine against Mycobacterium tuberculosis. J. Antimicrob. Chemother. 2002, 49, 275-282.
26. Sriram, D.; Yogeeswari, P.; Madhu, K. Synthesis and in Vivo Antimycobacterial Activity of Isonicotinoyl Hydrazones. Bioorg. Med. Chem. Lett. 2005, 15, 4502-4505.
27. Molecular Modeling Pro Plus, version 6.2.5; www.chemistry-software.com.
28. (a) Chatterjee, S.; Hadi, A. S. Influential Observations, High Leverage Points, and Outliers in Linear Regression. Stat. Sci. 1986, 1, 379-416.
29. (b) Kim, C.; Storer, B. E. Reference Values for Cook's Distance. Commun. Stat. - Theory and Methods 1996, 25, 691-708.
30. (c) Kim, C.; Lee, Y.; Park, B. U. Cook's Distance in Local Polynomial Regression. Stat. Probability Lett. 2001, 54, 33-40.
31. (d) Díaz-García, J. A.; González-Farías, G. A Note on the Cook's Distance. J. Stat. Planning Inference 2004, 120, 119-136.
32. (a) Serneels, S.; Croux, C.; Van Espen, P. J. Influence Properties of Partial Least Squares Regression. Chemom. Intell. Lab. Syst. 2004, 71, 13-20.
33. (b) Militino, A. F.; Palácios, M. B.; Ugarte, M. D. Outliers Detection in Multivariate Spatial Linear Models. J. Stat. Planning Inference 2006, 136, 125-146.
34. Eriksson, L.; Jaworska, J.; Worth, A. P.; Cronin, M. T. D.; McDowell, R. W. Methods for Reliability and Uncertainty Assessment and for Applicability Evaluations of Classification- and Regression- Based QSARs. Environ. Health Perspect. 2003, 111, 1361-1375.
35. Tropsha, A.; Gramatica, P.; Gombar, V. K. The Importance of Being Earnest: Validation Is the Absolute Essential for Successful Application and Interpretation of QSPR Models. QSAR Comb. Sci. 2003, 22, 69-77.
36. 2! J. Mol. Graphics. Modell. 2002, 20, 269-276.
37. (a) Abraham, M. H.; Martins, F.; Mitchell, R. C. Algorithms for Skin Permeability Using Hydrogen Bond Descriptors. J. Pharm. Pharmacol. 1997, 49, 858-865.
38. (b) Platts, J. A.; Abraham, M. H.; Butina, D.; Hersey, A. Estimation of Molecular Linear Free Energy Relationship Descriptors by a Group Contribution Approach. 2. Prediction of Partition Coefficients. J. Chem. Inf. Comput. Sci. 2000, 40, 71-80.
39. (c) Zissimos, A. M.; Abraham, M. H.; Barker, M. C.; Box, K. J.; Tam, K. Y. Calculation of Abraham Descriptors from Solvent-Water Partition Coefficients in Four Different Systems; Evaluation of Different Methods of Calculation. J. Chem. Soc., Perkin Trans. 2 2002, 470-477.
40. (d) Abraham, M. H.; Chada, H. S.; Martins, F.; Mitchell, R. C.; Bradbury, M. W.; Gratton, J. A. Hydrogen Bonding Part 46: A Review of the Correlation and Prediction of Transport Properties by an LFER Method: Physicochemical Properties, Brain Penetration and Skin Permeability Pestic. Sci. 1999, 55, 78-88.
41. Verloop, A.; Tipker, J. Pharmaco Chemistry Library. In QSAR in Drug Design and Toxicology; Hadzi, D., Jorman-Blazic, B., Eds.; Elsevier Science Publishers B. V.: Amsterdam, 1987; Vol. 10; pp 97-125.
42. Verma, R. P.; Kurup, A.; Mekapati, S. B.; Hansch, C. Bioorg. Chemical-Biological Interactions in Human. Med. Chem. 2003, 13, 933-948.
43. (a) Selassie, C. D. History of Quantitative Structure-Activity Relationships, 1. In Burger's Medicinal Chemistry and Drug Discovery, 6th ed.; Abraham, D. J., Ed.; John Wiley and Sons: New York, 2003; Vol. 1, pp 1-48.
44. (b) Tropsha, A. Recent Trends in Quantitative Structure-Activity Relationships. In Burger's Medicinal Chemistry and Drug Discovery, 6th ed.; Abraham, D. J., Ed.; John Wiley and Sons: New York, 2003; pp 49-76.
45. Abraham, M. H.; Martins, F. Human Skin Permeation and Partition: General Linear Free-Energy Relationship Analyses. J. Pharm. Sci. 2004, 93, 1508-1523.
46. Van Balen, G. P.; Martinet, C. M.; Caron, G.; Bouchard, G.; Reist, M.; Carrupt, P.-A; Fruttero, R.; Gasco, A.; Testa, B. Liposome/Water Lipophilicity: Methods, Information Content, and Pharmaceutical Applications. Med. Res. Rev. 2004, 24, 299-324.
47. Rodrigues, C.; Gameiro, P.; Prieto, M.; de Castro, B. Interaction of Rifampicin and Isoniazid with Large Unilamellar Liposomes: Spectroscopic Location Studies. Biochem. Biophys. Acta 2003, 1620, 151-159.
48. Wengenack, N. L.; Todorovic, S.; Yu, L.; Rusnak, F. Evidence for Differential Binding of Isoniazid by Mycobacterium tuberculosis KatG and the Isoniazid-Resistant Mutant KatG (S315T). Biochemistry 1998, 37, 15825-15834.
49. Powers, L.; Hillar, A.; Loewen, P. C. Active Site Structure of the Catalase-Peroxidases from Mycobacterium tuberculosis and Escherichia coli by Extended X-ray Absorption Fine Structure Analysis. Biochim. Biophys. Acta 2001, 1546, 44-54.
50. Wei, C.-J.; Lei, B.; Musser, J. M.; Tu, S.-C. Isoniazid Activation Defects in Recombinant Mycobacterium tuberculosis Catalase-Peroxidase (KatG) Mutants Evident in InhA Inhibitor Production. Antimicrob. Agents Chemother. 2003, 47, 670-675.
51. Pierattelli, R.; Banci, L.; Eady, N. A. J.; Bodiguel, J.; Jones, J. N.; Moody, P. C. E.; Raven, E. L.; Jamart-Grégoire, B.; Brown, A. Enzyme-Catalyzed Mechanism of Isoniazid Activation in Class I and Class III Peroxidases. J. Biol. Chem. 2004, 279, 39000-39009.
52. Bertrand, T.; Eady, N. A. J.; Jones, J. N.; Jesmin; Nagy, J. M.; Jamart-Grégoire, B.; Raven, E. L.; Brown, K. A. Crystal Structure of Mycobacterium tuberculosis Catalase-Peroxidase. J. Biol Chem. 2004, 279, 38991-38999.
53. Singh, R.; Wiseman, B.; Deemagarn, T.; Donald, L. J.; Duckworth, H. W.; Caipena, X.; Fita, I.; Loewen, P. C. Catalase-Peroxidases (KatG) Exhibit NADH Oxidase Activity. J. Biol. Chem. 2004, 279, 43098-43106.
54. Deemagarn, T.; Carpena, X.; Singh, R.; Wiseman, B.; Fita, I.; Loewen, C. Structural Characterization of the Ser324Thr Variant of the Catalase-Peroxidase (KatG) from Burkholderia pseudomallei. J. Mol. Biol. 2005, 345, 21-28.
55. Zhao, X.; Yu, H.; Yu, S.; Wang, F.; Sacchettini, J. C.; Magliozzo, R. S. Hydrogen Peroxide-Mediated Isoniazid Activation Catalyzed by Mycobacterium tuberculosis Catalase-Peroxidase (KatG) and Its S315T Mutant. Biochemistry 2006, 45, 4131-4140.